Vision-related quality of life in Japanese patients with wet age-related macular degeneration treated with intravitreal aflibercept in a real-world setting

被引：0
|
作者：
Fumi Gomi
Hideyuki Migita
Toshiaki Sakaguchi
Hiromi Okada
Tamotsu Sugawara
Yusuke Hikichi
机构：
[1] Hyogo College of Medicine Hospital,
[2] Bayer Yakuhin,undefined
[3] CMIC Co,undefined
[4] Ltd,undefined
来源：
Japanese Journal of Ophthalmology | 2019年 / 63卷
关键词：
Intravitreal aflibercept; NEI-VFQ-25; Wet age-related macular degeneration; J-PMS;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：437 / 447
页数：10
相关论文
共 50 条
  • [41] Comparison of Intravitreal Aflibercept with Bevacizumab and Ranibizumab for the Treatment of Wet Age-related Macular Degeneration
    Shaikh, Adeel
    Miller, Daniel
    Petersen, Michael
    Foster, Robert
    Riemann, Christopher
    Sisk, Robert
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2013, 54 (15)
  • [42] Effect of photobiomodulation on vision-related quality of life and visual acuity in patients with non exudative age-related macular degeneration: a real life study
    Derzi Romero, Ana Paula
    Andrs Francone, Anibal
    Gerardo Schlottmann, Patricio
    Zompa, Tamara
    Charles, Martin
    Paz Cirillo, Maria
    Donoso, Martina
    Sergio Pagani, Fernando
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2024, 65 (07)
  • [43] Real-World Experience Using Intravitreal Brolucizumab Alone or in Combination with Aflibercept in the Management of Neovascular Age-Related Macular Degeneration
    Mehta, Neesurg
    Fong, Rodney
    Wilson, Machelle
    Moussa, Kareem
    Emami-Naeini, Parisa
    Moshiri, Ala
    Yiu, Glenn
    Park, Susanna S.
    CLINICAL OPHTHALMOLOGY, 2023, 17 : 657 - 665
  • [44] Real-world 10-year experiences with intravitreal treatment with ranibizumab and aflibercept for neovascular age-related macular degeneration
    Brynskov, Troels
    Munch, Inger Christine
    Larsen, Tobias Malte
    Erngaard, Iiv
    Sorensen, Torben Lykke
    ACTA OPHTHALMOLOGICA, 2020, 98 (02) : 132 - 138
  • [45] Aflibercept for Intravitreal Injection In Neovascular Age-Related Macular Degeneration
    Frampton, James E.
    DRUGS & AGING, 2012, 29 (10) : 839 - 846
  • [46] Aflibercept for Intravitreal InjectionIn Neovascular Age-Related Macular Degeneration
    James E. Frampton
    Drugs & Aging, 2012, 29 : 839 - 846
  • [47] Changes in Quality of Life Among Patients Treated with Aflibercept for neovascular Age-related Macular Degeneration (nAMD)
    Wijeyakumar, Wijeyanthy
    Hong, Thomas
    Broadhead, Geoffrey
    Li, Haitao
    Zhu, Meidong
    Chang, Andrew Alexander
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2014, 55 (13)
  • [48] Ranibizumab and aflibercept for the treatment of wet age-related macular degeneration
    Yazdi, Mohammad Hossein
    Faramarzi, Mohammad All
    Nikfar, Shekoufeh
    Falavarjani, Khalil Ghasemi
    Abdollahi, Mohammad
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2015, 15 (09) : 1349 - 1358
  • [49] VISION-RELATED QUALITY OF LIFE AMONG PATIENTS TREATED WITH AFLIBERCEPT FOR AMD
    Wijeyakumar, Wijeyanthy
    Hong, Thomas
    Broadhead, Geoffrey K.
    Li, Haitao
    Zhu, Meidong
    Chang, Andrew A.
    CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 2013, 41 : 18 - 18
  • [50] Efficacy of Aflibercept in Refractory Wet Age-Related Macular Degeneration
    Choi, Catherine
    Zhang, Li
    Abramoff, Michael David
    Sonka, Milan
    Shifera, Amde
    Kay, Christine Nichols
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2014, 55 (13)
12345